Invention Application
- Patent Title: MODULATION OF KU86 EXPRESSION
- Patent Title (中): KU86表达式的调制
-
Application No.: PCT/US0337346Application Date: 2003-11-21
-
Publication No.: WO2004048523A3Publication Date: 2005-02-24
- Inventor: MONIA BRETT P , DOBIE KENNETH W , PANASCI LAWRENCE
- Applicant: ISIS PHARMACEUTICALS INC , MONIA BRETT P , DOBIE KENNETH W , PANASCI LAWRENCE
- Assignee: ISIS PHARMACEUTICALS INC,MONIA BRETT P,DOBIE KENNETH W,PANASCI LAWRENCE
- Current Assignee: ISIS PHARMACEUTICALS INC,MONIA BRETT P,DOBIE KENNETH W,PANASCI LAWRENCE
- Priority: US30412402 2002-11-23
- Main IPC: C12N5/02
- IPC: C12N5/02 ; C12N15/113 ; C12Q1/68 ; A01N43/04 ; C07H21/02 ; C07H21/04 ; C12N15/88 ; C12P19/34
Abstract:
Compounds, compositions and methods are provided for modulating the expression of Ku86. The compositions comprise oligonucleotides, targeted to nucleic acid encoding Ku86. Methods of using these compounds for modulation of Ku86 expression and for diagnosis and treatment of disease associated with expression of Ku86 are provided.
Information query
